EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Platelet activating factor: an inhibitor of neutrophil activation?



Platelet activating factor: an inhibitor of neutrophil activation?



Clinical and Experimental Immunology 43(1): 135-142



Preparations of platelet activating factor (PAF) derived by methanolic extraction of supernatants from antigen-challenged rabbit basophils proved capable of activating platelets while concurrently inhibiting neutrophil aggregation/secretion stimulated by biologically active F-Met peptides, ionophore A23187, or zymosan-treated serum. This inhibition was non-cytotoxic and species-non-specific. When these PAF preparations were analysed using thin-layer chromatography, multiple lipids were detected. Both platelet-stimulating as well as neutrophil-inhibitory activity was present in a lipid component migrating at an RF consistent with native PAF; however, these biological activities were not limited only to PAF and, indeed, could also be detected in lipid with solubility characteristics more closely related to a lysophosphatide than to native PAF. These data are compatible with the belief that native PAF may belong to a family of biologically active lipids differing somewhat in physico-chemical properties. Moreover, these data illustrate that PAF and/or PAF-like molecules may also demonstrate a biological activity distinct from their effects upon the platelet.

(PDF 0-2 workdays service: $29.90)

Accession: 006133743

Download citation: RISBibTeXText

PMID: 7249391



Related references

Opposing effects of platelet-activating factor and lyso-platelet-activating factor on neutrophil and platelet activation. Molecular Pharmacology 75(1): 227-234, 2008

Platelet-activating factor as an intercellular signal in neutrophil-dependent platelet activation. Journal of Immunology 149(5): 1763-1769, 1992

Activation of platelet-neutrophil mediated by platelet-activating factor. Zhongguo Shi Yan Xue Ye Xue Za Zhi 13(3): 447-451, 2005

Eosinophil migration in atopic dermatitis I: Increased migratory responses to N-formylmethionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet-activating factor, and platelet factor 4. Journal of Investigative Dermatology 100(2): 137-142, 1993

Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion. Journal of Surgical Research 55(5): 504-515, 1993

Activation of platelets by platelet activating factor derived from immuno globulin e sensitized basophils part 4 platelet activating factor does not activate platelet factor 3. British Journal of Haematology 34(2): 269-282, 1976

Desensitization of human platelet activating factor neutrophil cytosolic calcium changes and degranulation to paf acether platelet activating factor and formylmethionylleucylphenylalamine. British Journal of Pharmacology 84(SUPPL): 169P, 1985

Endothelial cell platelet-activating factor primes neutrophil responses: amplification of endothelial activation by neutrophil products. Journal of Lipid Mediators 2 Suppl: S23-S30, 1990

Ionic and GTP regulation of binding of platelet-activating factor to receptors and platelet-activating factor-induced activation of GTPase in rabbit platelet membranes. Journal of Biological Chemistry 261(2): 532-537, 1986

Drug modulation of human neutrophil activation evoked by platelet activating factor. Pharmacological Research Communications 20(supp-S1): 7-8, 1988

Fluid shear stress increases neutrophil activation via platelet-activating factor. Biophysical Journal 106(10): 2243-2253, 2015

The effects of a platelet activating factor antagonist l 652731 on paf and hemorrhagic hypotension and neutrophil activation. Federation Proceedings 46(4): 1262, 1987

Combined activation of platelets by cathepsin G and platelet activating factor, two neutrophil-derived agonists. British Journal of Haematology 80(2): 205-213, 1992

Platelet activating factor involvement in endotoxin induced thrombocytopenia in rabbits studies with fr 900452 a specific inhibitor of platelet activating factor. Thrombosis Research 42(5): 661-672, 1986